On ECHEMI
Home > Drugs > Reyoung Pharmaceutical Co., Ltd.
Reyoung Pharmaceutical Co., Ltd.
  • Founded in:

    1998-03-20
  • Country:

    China China
  • Address:

    No. 1, Ruiyang Road, Yiyuan County, Shandong Province
  • Tax NO.:

    913703001686121827
  • Registered Funds:

    366.74 million yuan
  • Website:

  • Email:

Related Drugs
Azithromycin for injection
Main ingredients: The main ingredient of this product is azithromycin. Its chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta;-D-xyl-pyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Structural formula: (see azithromycin dry suspension) Molecular formula: C38H72N2O12 Molecular weight: 749
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

More

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

83905-01-5 39
Azithromycin for injection
Main ingredients: The main ingredient of this product is azithromycin. Its chemical name is (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-beta;-D-xyl-pyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Structural formula: (see azithromycin dry suspension) Molecular formula: C38H72N2O12 Molecular weight: 749
Name Description Content CAS NO. Registered Holders
Azithromycin

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

More

Azithromycin is a 15-membered macrolide antibiotic. In vitro tests have shown that azithromycin has antibacterial effects on a variety of common clinical pathogens, including: Gram-positive aerobic bacteria, Staphylococcus aureus, Streptococcus pyogenes (group A beta; hemolytic streptococci), pneumonia (streptococci), a-hemolytic streptococci (grass-green streptococci) and other streptococci, diphtheria (rod-shaped) bacilli. This product shows cross-resistance to erythromycin-resistant Gram-positive bacteria, including fecal streptococci (enterococci) and various methicillin-resistant Staphylococcus strains.

83905-01-5 39
Yanhuning
The main ingredient of this product is indomethacin, and its chemical name is 14-dehydroxy-11,12-didehydroandrographolide-3,19-disuccinic acid hemiester potassium sodium salt-hydrate.
Name Description Content CAS NO. Registered Holders
PotassiuM sodiuM Dehydroandrographolide Succinate

This product is a potassium sodium salt of dehydrated andrographolide succinate half ester, which is refined by esterification, dehydration and salt formation of andrographolide extract from the plant Andrographis paniculata. The pharmacological effects include: 1) It has a strong antipyretic effect on rabbits with fever caused by bacterial endotoxins; 2) It can counteract the increased permeability of capillary walls caused by xylene or histamine; 3) It has a significant sedative effect; 4) It can significantly promote the adrenal cortex function of rats and enhance the body's emergency response to pathogen infection; 5) It has a certain inactivation effect on influenza virus type I, type III, pneumonia adenovirus (Adv) type III, type IV, enterosyncytial virus and respiratory syncytial virus (RSV) in vitro.

More

This product is a potassium sodium salt of dehydrated andrographolide succinate half ester, which is refined by esterification, dehydration and salt formation of andrographolide extract from the plant Andrographis paniculata. The pharmacological effects include: 1) It has a strong antipyretic effect on rabbits with fever caused by bacterial endotoxins; 2) It can counteract the increased permeability of capillary walls caused by xylene or histamine; 3) It has a significant sedative effect; 4) It can significantly promote the adrenal cortex function of rats and enhance the body's emergency response to pathogen infection; 5) It has a certain inactivation effect on influenza virus type I, type III, pneumonia adenovirus (Adv) type III, type IV, enterosyncytial virus and respiratory syncytial virus (RSV) in vitro.

863319-40-8 43
Propacetamol Hydrochloride for Injection
Propacetamol. 4-(Acetylamino)phenyl N,N-diethylglycinate hydrochloride.
Name Description Content CAS NO. Registered Holders
Propacetamol

A prodrug of acetaminophen, it produces analgesic effects by inhibiting the production and release of endogenous pain-causing substances through inhibiting arachidonic acid metabolism; it selectively inhibits the production of prostaglandins in the central nervous system, producing analgesic effects similar to those of morphine, and is used for postoperative analgesia; injection also has sedative and antipyretic effects, and is suitable for acute cases such as high fever and pain, or for patients who are not suitable for oral medication, and has no tolerance or dependence.

More

A prodrug of acetaminophen, it produces analgesic effects by inhibiting the production and release of endogenous pain-causing substances through inhibiting arachidonic acid metabolism; it selectively inhibits the production of prostaglandins in the central nervous system, producing analgesic effects similar to those of morphine, and is used for postoperative analgesia; injection also has sedative and antipyretic effects, and is suitable for acute cases such as high fever and pain, or for patients who are not suitable for oral medication, and has no tolerance or dependence.

66532-85-2 11
Propacetamol Hydrochloride for Injection
Propacetamol. 4-(Acetylamino)phenyl N,N-diethylglycinate hydrochloride.
Name Description Content CAS NO. Registered Holders
Propacetamol

The prodrug of acetaminophen inhibits the production and release of endogenous pain-causing substances by inhibiting arachidonic acid metabolism, selectively inhibits the production of central prostaglandins, and produces analgesic effects; injection has sedative and antipyretic effects, and is suitable for postoperative analgesia, high fever cases, and prevention of convulsions. There is no tolerance and dependence.

More

The prodrug of acetaminophen inhibits the production and release of endogenous pain-causing substances by inhibiting arachidonic acid metabolism, selectively inhibits the production of central prostaglandins, and produces analgesic effects; injection has sedative and antipyretic effects, and is suitable for postoperative analgesia, high fever cases, and prevention of convulsions. There is no tolerance and dependence.

66532-85-2 11
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.